Literature DB >> 22871386

TRPM7 is required for breast tumor cell metastasis.

Jeroen Middelbeek1, Arthur J Kuipers, Linda Henneman, Daan Visser, Ilse Eidhof, Remco van Horssen, Bé Wieringa, Sander V Canisius, Wilbert Zwart, Lodewyk F Wessels, Fred C G J Sweep, Peter Bult, Paul N Span, Frank N van Leeuwen, Kees Jalink.   

Abstract

TRPM7 encodes a Ca2+-permeable nonselective cation channel with kinase activity. TRPM7 has been implicated in control of cell adhesion and migration, but whether TRPM7 activity contributes to cancer progression has not been established. Here we report that high levels of TRPM7 expression independently predict poor outcome in breast cancer patients and that it is functionally required for metastasis formation in a mouse xenograft model of human breast cancer. Mechanistic investigation revealed that TRPM7 regulated myosin II-based cellular tension, thereby modifying focal adhesion number, cell-cell adhesion and polarized cell movement. Our findings therefore suggest that TRPM7 is part of a mechanosensory complex adopted by cancer cells to drive metastasis formation. ©2012 AACR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22871386     DOI: 10.1158/0008-5472.CAN-11-3863

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  91 in total

Review 1.  Role of TRP ion channels in cancer and tumorigenesis.

Authors:  George Shapovalov; Abigael Ritaine; Roman Skryma; Natalia Prevarskaya
Journal:  Semin Immunopathol       Date:  2016-02-03       Impact factor: 9.623

2.  TRPM6 kinase activity regulates TRPM7 trafficking and inhibits cellular growth under hypomagnesic conditions.

Authors:  Katherine Brandao; Francina Deason-Towne; Xiaoyun Zhao; Anne-Laure Perraud; Carsten Schmitz
Journal:  Cell Mol Life Sci       Date:  2014-05-25       Impact factor: 9.261

3.  TRPM7 triggers Ca2+ sparks and invadosome formation in neuroblastoma cells.

Authors:  Daan Visser; Michiel Langeslag; Katarzyna M Kedziora; Jeffrey Klarenbeek; Alwin Kamermans; F David Horgen; Andrea Fleig; Frank N van Leeuwen; Kees Jalink
Journal:  Cell Calcium       Date:  2013-10-16       Impact factor: 6.817

Review 4.  Transient receptor potential (TRP) channels and cardiac fibrosis.

Authors:  Zhichao Yue; Yanhui Zhang; Jia Xie; Jianmin Jiang; Lixia Yue
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

5.  Suppression of TRPM7 inhibits proliferation, migration, and invasion of malignant human glioma cells.

Authors:  Tian-Dong Leng; Ming-Hua Li; Jian-Feng Shen; Ming-Li Liu; Xin-Bo Li; Hua-Wei Sun; Debbie Branigan; Zhao Zeng; Hong-Fang Si; Jun Li; Jeff Chen; Zhi-Gang Xiong
Journal:  CNS Neurosci Ther       Date:  2014-12-01       Impact factor: 5.243

Review 6.  Ca2+ as a therapeutic target in cancer.

Authors:  Scott Gross; Pranava Mallu; Hinal Joshi; Bryant Schultz; Christina Go; Jonathan Soboloff
Journal:  Adv Cancer Res       Date:  2020-07-09       Impact factor: 6.242

Review 7.  Constitutive calcium entry and cancer: updated views and insights.

Authors:  Olivier Mignen; Bruno Constantin; Marie Potier-Cartereau; Aubin Penna; Mathieu Gautier; Maxime Guéguinou; Yves Renaudineau; Kenji F Shoji; Romain Félix; Elsa Bayet; Paul Buscaglia; Marjolaine Debant; Aurélie Chantôme; Christophe Vandier
Journal:  Eur Biophys J       Date:  2017-05-17       Impact factor: 1.733

8.  The kinase activity of the channel-kinase protein TRPM7 regulates stability and localization of the TRPM7 channel in polarized epithelial cells.

Authors:  Na Cai; Liping Lou; Namariq Al-Saadi; Sandra Tetteh; Loren W Runnels
Journal:  J Biol Chem       Date:  2018-06-04       Impact factor: 5.157

Review 9.  Calcium influx pathways in breast cancer: opportunities for pharmacological intervention.

Authors:  I Azimi; S J Roberts-Thomson; G R Monteith
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

Review 10.  Proton-sensitive cation channels and ion exchangers in ischemic brain injury: new therapeutic targets for stroke?

Authors:  Tiandong Leng; Yejie Shi; Zhi-Gang Xiong; Dandan Sun
Journal:  Prog Neurobiol       Date:  2014-01-24       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.